ELAN FY 2018 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$3.1B+6.2% YoY

Gross Profit

$1.3B42.2% margin

Operating Income

$314M10.2% margin

Net Income

$87M2.8% margin

EPS (Diluted)

$0.28

Cash Flow

Operating Cash Flow

$487M

Free Cash Flow

$353M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$9.0B

Total Liabilities

$3.8B

Stockholders' Equity

$5.2B

Cash & Equivalents

$475M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.1B	$2.9B	+6.2%
Gross Profit	$1.3B	$1.2B	+10.4%
Operating Income	$314M	$142M	+120.4%
Net Income	$87M	-$311M	+127.8%